Authors:
JENNINGS I
KITCHEN S
WOODS TAL
PRESTON FE
Citation: I. Jennings et al., LABORATORY PERFORMANCE OF HEMOPHILIA CENTERS IN DEVELOPING-COUNTRIES - 3 YEARS EXPERIENCE OF THE WORLD-FEDERATION-OF-HEMOPHILIA EXTERNAL QUALITY ASSESSMENT SCHEME, Haemophilia, 4(5), 1998, pp. 739-746
Authors:
BEAUCHAMP NJ
DALY ME
MAKRIS M
PRESTON FE
PEAKE IR
Citation: Nj. Beauchamp et al., A NOVEL MUTATION IN INTRON-K OF THE PROS1 GENE CAUSES ABERRANT RNA SPLICING AND IS A COMMON-CAUSE OF PROTEIN-S DEFICIENCY IN A UK THROMBOPHILIA COHORT, Thrombosis and haemostasis, 79(6), 1998, pp. 1086-1091
Authors:
ROSENDAAL FR
DOGGEN CJM
ZIVELIN A
ARRUDA VR
AIACH M
SISCOVICK DS
HILLARP A
WATZKE HH
BERNARDI F
CUMMING AM
PRESTON FE
REITSMA PH
Citation: Fr. Rosendaal et al., GEOGRAPHIC-DISTRIBUTION OF THE 20210-G TO 20210-A PROTHROMBIN VARIANT, Thrombosis and haemostasis, 79(4), 1998, pp. 706-708
Authors:
WILLIAMS IJ
ABUZENADAH A
WINSHIP PR
PRESTON FE
DOLAN G
WRIGHT J
PEAKE IR
GOODEVE AC
Citation: Ij. Williams et al., PRECISE CARRIER DIAGNOSIS IN FAMILIES WITH HEMOPHILIA-A - USE OF CONFORMATION SENSITIVE GEL-ELECTROPHORESIS FOR MUTATION SCREENING AND POLYMORPHISM ANALYSIS, Thrombosis and haemostasis, 79(4), 1998, pp. 723-726
Authors:
HAY CRM
LUDLAM CA
COLVIN BT
HILL FGH
PRESTON FE
WASSEEM N
BAGNALL R
PEAKE IR
BERNTORP E
BUNSCHOTEN EPM
FIJNVANDRAAT K
KASPER CK
WHITE G
SANTAGOSTINO E
Citation: Crm. Hay et al., FACTOR-VIII INHIBITORS IN MILD AND MODERATE-SEVERITY HEMOPHILIA-A, Thrombosis and haemostasis, 79(4), 1998, pp. 762-766
Authors:
PERRY DJ
DALY ME
TAIT RC
WALKER ID
BROWN K
BEAUCHAMP NJ
PRESTON FE
GYDE H
HARPER PL
CARRELL RW
Citation: Dj. Perry et al., ANTITHROMBIN CAMBRIDGE-II (ALA384SER) - CLINICAL, FUNCTIONAL AND HAPLOTYPE ANALYSIS OF 18 FAMILIES, Thrombosis and haemostasis, 79(2), 1998, pp. 249-253
Authors:
LAWRIE AS
KITCHEN S
PURDY G
MACKIE IJ
PRESTON FE
MACHIN SJ
Citation: As. Lawrie et al., ASSESSMENT OF ACTIN FS AND ACTIN FSL SENSITIVITY TO SPECIFIC CLOTTINGFACTOR DEFICIENCIES, Clinical and laboratory haematology, 20(3), 1998, pp. 179-186
Authors:
WOODS TAL
JENNINGS I
KITCHEN S
PRESTON FE
Citation: Tal. Woods et al., NEAR PATIENT TESTING IN BLOOD-COAGULATION - 18 MONTHS OF UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME SURVEYS, British Journal of Haematology, 102(1), 1998, pp. 260-260
Authors:
KITCHEN S
JENNINGS I
WOODS TAL
PRESTON FE
Citation: S. Kitchen et al., LOCAL CALIBRATION OF THROMBOPLASTIN INSTRUMENT SYSTEMS FOR INTERNATIONAL NORMALIZED RATIO (INR) DETERMINATION - DIFFERENT CALIBRANTS ARE ASSOCIATED WITH DIFFERENT INR RESULTS, British Journal of Haematology, 101, 1998, pp. 223-223
Citation: R. Iampietro et al., CLINICALLY IMPORTANT DIFFERENCES BETWEEN ANTI XA ASSAY RESULTS DURINGLOW-MOLECULAR-WEIGHT HEPARIN OR DANAPAROID THERAPY, British Journal of Haematology, 101, 1998, pp. 224-224
Authors:
NESBITT IM
GOODEVE AC
HAMPTON KK
PRESTON FE
PEAKE IR
Citation: Im. Nesbitt et al., 2 UNRELATED FAMILIES WITH DIFFERENT TYPE-2N VWD MUTATIONS SHARE A COMMON SPLICE-SITE MUTATION, British Journal of Haematology, 101, 1998, pp. 258-258
Citation: M. Leach et al., NORETHISTERONE THERAPY FOR BLEEDING DUE TO GASTROINTESTINAL TELANGIECTASES IN GLANZMANNS-THROMBASTHENIA, British Journal of Haematology, 100(3), 1998, pp. 594-596
Citation: Kk. Hampton et Fe. Preston, ABC OF CLINICAL HEMATOLOGY - BLEEDING DISORDERS, THROMBOSIS, AND ANTICOAGULATION, BMJ. British medical journal, 314(7086), 1997, pp. 1026-1029
Authors:
MAKRIS M
PRESTON FE
BEAUCHAMP NJ
HAMPTON KK
DALY ME
COOPER P
BAYLISS P
PEAKE IR
Citation: M. Makris et al., CO-INHERITANCE OF THE 20210A ALLELE OF THE PROTHROMBIN GENE INCREASESTHE THROMBOTIC RISK IN SUBJECTS WITH FAMILIAL THROMBOPHILIA, Thrombosis and haemostasis, 1997, pp. 672-672
Authors:
PERRY DJ
DALY ME
TAIT RC
WALKER ID
BROWN K
BEAUCHAMP NJ
PRESTON FE
GYDE H
HARPER PL
CARRELL RW
Citation: Dj. Perry et al., A COMMON MUTATION IN THE ANTITHROMBIN GENE - ALA384SER - CLINICAL, FUNCTIONAL AND HAPLOTYPE ANALYSIS OF 18 FAMILIES, Thrombosis and haemostasis, 1997, pp. 766-766
Authors:
THEAKER J
KITCHEN S
PHILIPS JK
PRESTON FE
Citation: J. Theaker et al., COMPARISON OF 8 COMMERCIAL ANTI-XA ASSAYS AND THE HEPARIN ASSAY BY PROTAMINE TITRATION IN PATIENTS RECEIVING UNFRACTIONATED HEPARIN, Thrombosis and haemostasis, 1997, pp. 1133-1133
Citation: I. Jennings et al., MONITORING HEPARIN-THERAPY - INSTRUMENT EFFECTS ON REAGENT SENSITIVITY - RESULTS FROM UK NEQAS FOR BLOOD-COAGULATION, Thrombosis and haemostasis, 1997, pp. 1141-1141